5 pre-IPO risks advisors flag after Anthropic

Anthropic’s transfer warning highlights five common risks in pre-IPO share deals.

Anthropic’s move to void unauthorized transfers has put fresh attention on pre-IPO investing, where a single approval issue can change what a client actually owns. With the company targeting a public listing as soon as October 2026 and annualized revenue cited at $19 billion, advisors are reminding clients that access is not the same as ownership.

1. Transfer approval can decide whether shares count

The biggest lesson from Anthropic’s announcement is simple: if the board did not approve the transfer, the company may treat it as void. That means a buyer can pay for what looks like equity exposure and still end up with no recognized claim at the company level.

Haley Schaffer of Waypoint West says clients often do not realize how much of the risk sits in the paperwork, not the pitch. In her view, investors should ask who approved the transaction, whether the seller had authority, and whether the company has a written record that the transfer was allowed.

• Ask for board approval or written consent
• Confirm whether the transfer agent recognizes the trade
• Check if the company has a pre-approved buyer list

2. Illiquidity can last longer than expected

Pre-IPO shares are not public securities, so there is no guarantee of a quick exit. Seth Hickle of Mindset Wealth Management tells clients to expect delayed, rejected, or conditional transfers, plus a long wait for a liquidity event that may not arrive on schedule.

This matters because the timeline is often part of the sales story. A company may be discussed as a near-term IPO candidate, but markets, boards, and underwriters can move on different clocks. For clients who need flexibility, that mismatch can create pressure long before any listing happens.

• No public market to sell into
• Exit depends on IPO, acquisition, or tender offer
• Timing can slip by quarters or years

3. Pricing can be hard to verify

Private shares do not trade on a live exchange, so the price a client pays may reflect a negotiated deal, not a transparent market. That makes it hard to know whether the buyer is getting a fair entry point or paying for excitement around the company name.

Schaffer notes that some investors chase a logo instead of asking what they are actually buying. If the goal is exposure to the AI build-out, she suggests looking at related areas such as infrastructure, semiconductors, data centers, energy, and private credit rather than assuming a single private company is the only path.

4. Side agreements can add hidden restrictions

Pre-IPO deals often come with rights of first refusal, consent rights, clawbacks, dilution clauses, ratchets, tag-along rights, confidentiality terms, and other conditions that are easy to miss if the focus stays on the headline company name. Those terms can affect both control and economics.

Schaffer says bad actors often exploit confusion by misrepresenting approval status or using unauthorized structures. The danger is not only that the transfer gets rejected, but that the investor learns too late that the deal was never clean to begin with.

• Right of first refusal can block resale
• Clawbacks can force shares back under certain events
• Dilution clauses can reduce future ownership

5. Demand can push clients toward FOMO trades

Hot private names can trigger a fear-of-missing-out response, especially when headlines point to large revenue figures or a possible blockbuster IPO. But Hickle says demand should never override risk management, since private investments require tolerance for complexity, uncertainty, and limited transparency.

That is why advisors are emphasizing suitability. A client who wants exposure to AI may be better served by public companies tied to the build-out, while a client who truly wants direct private exposure needs to understand the tradeoffs and stay within properly structured channels.

• Match the investment to the client’s liquidity needs
• Stress-test the position against a long hold period
• Use documented, approved channels only

How to decide

If a client wants direct ownership in a private company, the key question is whether the transfer is fully approved and clearly documented. If not, the risk may be too high for most investors, especially those who need liquidity or cannot tolerate a long hold.

If the goal is broader exposure to AI growth, advisors may find better fit in public markets or in private-market themes with clearer structure. The main test is not whether the name is exciting, but whether the client can live with the rules that come with private ownership.